{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["endometrial cancer", "hormone-sensitive cancer", "medicinal plants", "metastasis", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35264951", "DateRevised": {"Year": "2022", "Month": "03", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "21"}], "Language": ["eng"], "ELocationID": ["801733", "10.3389/fphar.2022.801733"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.", "Pagination": {"StartPage": "801733", "MedlinePgn": "801733"}, "Abstract": {"AbstractText": ["Endometrial cancer (EC) is the sixth most prevalent type of cancer among women. Kinases, enzymes mediating the transfer of adenosine triphosphate (ATP) in several signaling pathways, play a significant role in carcinogenesis and cancer cells' survival and proliferation. Cyclin-dependent kinases (CDKs) are involved in EC pathogenesis; therefore, CDK inhibitors (CDKin) have a noteworthy therapeutic potential in this type of cancer, particularly in EC type 1. Natural compounds have been used for decades in the treatment of cancer serving as a source of anticancer bioactive molecules. Many phenolic and non-phenolic natural compounds covering flavonoids, stilbenoids, coumarins, biphenyl compounds, alkaloids, glycosides, terpenes, and terpenoids have shown moderate to high effectiveness against CDKin-mediated carcinogenic signaling pathways (PI3K, ERK1/2, Akt, ATM, mTOR, TP53). Pharmaceutical regimens based on two natural compounds, trabectedin and ixabepilone, have been investigated in humans showing short and midterm efficacy as second-line treatments in phase II clinical trials. The purpose of this review is twofold: the authors first provide an overview of the involvement of kinases and kinase inhibitors in the pathogenesis and treatment of EC and then discuss the existing evidence about natural products' derived kinase inhibitors in the management of the disease and outline relevant future research."], "CopyrightInformation": "Copyright \u00a9 2022 Singla, Behzad, Khan, Tsagkaris, Gautam, Goyal, Chopra and Shen."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."}, {"Identifier": [], "Affiliation": "IGlobal Research and Publishing Foundation, New Delhi, India."}], "LastName": "Singla", "ForeName": "Rajeev K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Behzad", "ForeName": "Sahar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Health and Basic Sciences Research Center, Majmaah University, Majmaah, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Johra", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, University of Crete, Heraklion, Greece."}], "LastName": "Tsagkaris", "ForeName": "Christos", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, MM School of Pharmacy, MM University, Ambala, India."}], "LastName": "Gautam", "ForeName": "Rupesh K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, MM School of Pharmacy, MM University, Ambala, India."}], "LastName": "Goyal", "ForeName": "Rajat", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Rajpura, India."}], "LastName": "Chopra", "ForeName": "Hitesh", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."}], "LastName": "Shen", "ForeName": "Bairong", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "Author RS is honorary-based associated with the iGlobal Research and Publishing Foundation (iGRPF), India. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmad M. Z., Akhter S., Jain G. K., Rahman M., Pathan S. A., Ahmad F. J., et al. (2010). Metallic Nanoparticles: Technology Overview & Drug Delivery Applications in Oncology. Expert Opin. Drug Deliv. 7 (8), 927\u2013942. 10.1517/17425247.2010.498473", "ArticleIdList": ["10.1517/17425247.2010.498473", "20645671"]}, {"Citation": "Ahn M. Y., Jung J. H., Na Y. J., Kim H. S. (2008). A Natural Histone Deacetylase Inhibitor, Psammaplin A, Induces Cell Cycle Arrest and Apoptosis in Human Endometrial Cancer Cells. Gynecol. Oncol. 108 (1), 27\u201333. 10.1016/j.ygyno.2007.08.098", "ArticleIdList": ["10.1016/j.ygyno.2007.08.098", "17920664"]}, {"Citation": "Akbani R., Levine D. A. (2016). \u201cAbstract 133: Integrated Molecular Characterization of Uterine Carcinosarcoma in the Cancer Genome Atlas (TCGA) Project,\u201d in AACR 107th Annual Meeting 2016, New Orleans, LA, April 16-20, 2016 (New Orleans: Molecular and Cellular Biology, Genetics; ). 10.1158/1538-7445.am2016-133", "ArticleIdList": ["10.1158/1538-7445.am2016-133"]}, {"Citation": "Akhter S., Ahmad Z., Singh A., Ahmad I., Rahman M., Anwar M., et al. (2011). Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern. Curr. Pharm. Des. 17 (18), 1834\u20131850. 10.2174/138161211796391001", "ArticleIdList": ["10.2174/138161211796391001", "21568874"]}, {"Citation": "Ali I. U. (2000). Gatekeeper for Endometrium: the PTEN Tumor Suppressor Gene. J. Natl. Cancer Inst. 92 (11), 861\u2013863. 10.1093/jnci/92.11.861", "ArticleIdList": ["10.1093/jnci/92.11.861", "10841815"]}, {"Citation": "Ambros R. A., Kurman R. J. (1992). Combined Assessment of Vascular and Myometrial Invasion as a Model to Predict Prognosis in Stage I Endometrioid Adenocarcinoma of the Uterine Corpus. Cancer 69 (6), 1424\u20131431. 10.1002/1097-0142(19920315)69:6<1424::aid-cncr2820690620>3.0.co;2-5", "ArticleIdList": ["10.1002/1097-0142(19920315)69:6<1424::aid-cncr2820690620>3.0.co;2-5", "1371712"]}, {"Citation": "An J., Li L., Zhang X. (2020). Curcusone C Induces Apoptosis in Endometrial Cancer Cells via Mitochondria-dependent Apoptotic and ERK Pathway. Biotechnol. Lett. 43 (1), 329\u2013338. 10.1007/s10529-020-03027-4", "ArticleIdList": ["10.1007/s10529-020-03027-4", "33108571"]}, {"Citation": "Appadurai P., Rathinasamy K. (2015). Plumbagin-silver Nanoparticle Formulations Enhance the Cellular Uptake of Plumbagin and its Antiproliferative Activities. IET Nanobiotechnol 9 (5), 264\u2013272. 10.1049/iet-nbt.2015.0008", "ArticleIdList": ["10.1049/iet-nbt.2015.0008", "26435279"]}, {"Citation": "Arora S., Singh S., Piazza G. A., Contreras C. M., Panyam J., Singh A. P. (2012). Honokiol: a Novel Natural Agent for Cancer Prevention and Therapy. Curr. Mol. Med. 12 (10), 1244\u20131252. 10.2174/156652412803833508", "ArticleIdList": ["10.2174/156652412803833508", "PMC3663139", "22834827"]}, {"Citation": "Augustijns P., Wuyts B., Hens B., Annaert P., Butler J., Brouwers J. (2014). A Review of Drug Solubility in Human Intestinal Fluids: Implications for the Prediction of Oral Absorption. Eur. J. Pharm. Sci. 57, 322\u2013332. 10.1016/j.ejps.2013.08.027", "ArticleIdList": ["10.1016/j.ejps.2013.08.027", "23994640"]}, {"Citation": "Baier A., Galicka A., Nazaruk J., Szyszka R. (2017). Selected Flavonoid Compounds as Promising Inhibitors of Protein Kinase CK2\u03b1 and CK2\u03b1', the Catalytic Subunits of CK2. Phytochemistry 136, 39\u201345. 10.1016/j.phytochem.2016.12.018", "ArticleIdList": ["10.1016/j.phytochem.2016.12.018", "28043654"]}, {"Citation": "Baier A., Szyszka R. (2020). Compounds from Natural Sources as Protein Kinase Inhibitors. Biomolecules 10 (11). 10.3390/biom10111546", "ArticleIdList": ["10.3390/biom10111546", "PMC7698043", "33198400"]}, {"Citation": "Banik K., Ranaware A. M., Deshpande V., Nalawade S. P., Padmavathi G., Bordoloi D., et al. (2019). Honokiol for Cancer Therapeutics: A Traditional Medicine that Can Modulate Multiple Oncogenic Targets. Pharmacol. Res. 144, 192\u2013209. 10.1016/j.phrs.2019.04.004", "ArticleIdList": ["10.1016/j.phrs.2019.04.004", "31002949"]}, {"Citation": "Bansal H., Singla R. K., Behzad S., Chopra H., Grewal A. S., Shen B. (2021). Unleashing the Potential of Microbial Natural Products in Drug Discovery: Focusing on Streptomyces as Antimicrobials Goldmine. Ctmc 21, 2374\u20132396. 10.2174/1568026621666210916170110", "ArticleIdList": ["10.2174/1568026621666210916170110", "34530711"]}, {"Citation": "Bashir S., Jiang G., Joshi A., Miller C., Jr., Matrai C., Yemelyanova A., et al. (2014). Molecular Alterations of PIK3CA in Uterine Carcinosarcoma, clear Cell, and Serous Tumors. Int. J. Gynecol. Cancer 24 (7), 1262\u20131267. 10.1097/IGC.0000000000000183", "ArticleIdList": ["10.1097/IGC.0000000000000183", "25078343"]}, {"Citation": "Berry E., Hardt J. L., Clardy J., Lurain J. R., Kim J. J. (2009). Induction of Apoptosis in Endometrial Cancer Cells by Psammaplysene A Involves FOXO1. Gynecol. Oncol. 112 (2), 331\u2013336. 10.1016/j.ygyno.2008.10.017", "ArticleIdList": ["10.1016/j.ygyno.2008.10.017", "PMC2662924", "19041124"]}, {"Citation": "Bhullar K. S., Lagar\u00f3n N. O., McGowan E. M., Parmar I., Jha A., Hubbard B. P., et al. (2018). Kinase-targeted Cancer Therapies: Progress, Challenges and Future Directions. Mol. Cancer 17 (1), 48. 10.1186/s12943-018-0804-2", "ArticleIdList": ["10.1186/s12943-018-0804-2", "PMC5817855", "29455673"]}, {"Citation": "Bitto A., Granese R., Polito F., Triolo O., Giordano D., Squadrito F., et al. (2015). Genistein Reduces Angiogenesis and Apoptosis in Women with Endometrial Hyperplasia. Btat 2015 (5), 27\u201332. 10.2147/btat.S67368", "ArticleIdList": ["10.2147/btat.S67368"]}, {"Citation": "Bruchim I., Sarfstein R., Reiss A., Flescher E., Werner H. (2014). IGF1R Tyrosine Kinase Inhibitor Enhances the Cytotoxic Effect of Methyl Jasmonate in Endometrial Cancer. Cancer Lett. 352 (2), 214\u2013219. 10.1016/j.canlet.2014.06.013", "ArticleIdList": ["10.1016/j.canlet.2014.06.013", "24997432"]}, {"Citation": "Byron S. A., Gartside M., Powell M. A., Wellens C. L., Gao F., Mutch D. G., et al. (2012). FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features. PLoS ONE 7 (2), e30801. 10.1371/journal.pone.0030801", "ArticleIdList": ["10.1371/journal.pone.0030801", "PMC3285611", "22383975"]}, {"Citation": "Cairns J. (1998). Mutation and Cancer: the Antecedents to Our Studies of Adaptive Mutation. Genetics 148 (4), 1433\u20131440. 10.1093/genetics/148.4.1433", "ArticleIdList": ["10.1093/genetics/148.4.1433", "PMC1460072", "9560363"]}, {"Citation": "Cancer Genome Atlas Research Network (2017). Electronic address, a.a.d.h.e., and Cancer Genome Atlas Research, NIntegrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell 32 (2), 185\u2013203. e113. 10.1016/j.ccell.2017.07.007", "ArticleIdList": ["10.1016/j.ccell.2017.07.007", "PMC5964983", "28810144"]}, {"Citation": "Catas\u00fas L., Matias-Guiu X., Machin P., Mu\u00f1oz J., Prat J. (1998). BAX Somatic Frameshift Mutations in Endometrioid Adenocarcinomas of the Endometrium: Evidence for a Tumor Progression Role in Endometrial Carcinomas with Microsatellite Instability. Lab. Invest. 78 (11), 1439\u20131444.", "ArticleIdList": ["9840618"]}, {"Citation": "Chen H. Y., Cheng W. P., Chiang Y. F., Hong Y. H., Ali M., Huang T. C., et al. (2021). Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and P53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE). Int. J. Mol. Sci. 22 (15), 8268. 10.3390/ijms22158268", "ArticleIdList": ["10.3390/ijms22158268", "PMC8348875", "34361036"]}, {"Citation": "Chen S., Wu Z., Ke Y., Shu P., Chen C., Lin R., et al. (2019). Wogonoside Inhibits Tumor Growth and Metastasis in Endometrial Cancer via ER Stress-Hippo Signaling axis. Acta Biochim. Biophys. Sinica. 10.1093/abbs/gmz109", "ArticleIdList": ["10.1093/abbs/gmz109", "31696210"]}, {"Citation": "Chen Y., Yang L., Hu H., Chen J., Shen B. (2017). How to Become a Smart Patient in the Era of Precision Medicine? Adv. Exp. Med. Biol. 1028, 1\u201316. 10.1007/978-981-10-6041-0_1", "ArticleIdList": ["10.1007/978-981-10-6041-0_1", "29058213"]}, {"Citation": "Chen Y., Liu X., Yu Y., Yu C., Yang L., Lin Y., et al. (2020). PCaLiStDB: a Lifestyle Database for Precision Prevention of Prostate Cancer. Database J. Biol. Databases Curation 2020. 10.1093/database/baz154", "ArticleIdList": ["10.1093/database/baz154", "PMC6966110", "31950190"]}, {"Citation": "Cheng P., Ma J., Zheng X., Zhou C., Chen X. (2021). Bioinformatic Profiling Identifies Prognosis-Related Genes in the Immune Microenvironment of Endometrial Carcinoma. Sci. Rep. 11 (1), 12608. 10.1038/s41598-021-92091-5", "ArticleIdList": ["10.1038/s41598-021-92091-5", "PMC8206132", "34131259"]}, {"Citation": "Cho J. H., Lee J. G., Yang Y. I., Kim J. H., Ahn J. H., Baek N. I., et al. (2011). Eupatilin, a Dietary Flavonoid, Induces G2/M Cell Cycle Arrest in Human Endometrial Cancer Cells. Food Chem. Toxicol. 49 (8), 1737\u20131744. 10.1016/j.fct.2011.04.019", "ArticleIdList": ["10.1016/j.fct.2011.04.019", "21554918"]}, {"Citation": "Chopra H., Dey P. S., Das D., Bhattacharya T., Shah M., Mubin S., et al. (2021). Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets. Molecules 26 (16). 10.3390/molecules26164998", "ArticleIdList": ["10.3390/molecules26164998", "PMC8402133", "34443593"]}, {"Citation": "Choudhari A. S., Mandave P. C., Deshpande M., Ranjekar P., Prakash O. (2019). Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front. Pharmacol. 10, 1614. 10.3389/fphar.2019.01614", "ArticleIdList": ["10.3389/fphar.2019.01614", "PMC7025531", "32116665"]}, {"Citation": "Chrastina A., Baron V. T., Abedinpour P., Rondeau G., Welsh J., Borgstr\u00f6m P. (2018). Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells. Biomed. Res. Int. 2018, 9035452\u20139035457. 10.1155/2018/9035452", "ArticleIdList": ["10.1155/2018/9035452", "PMC6252225", "30534567"]}, {"Citation": "Desai N. (2012). Challenges in Development of Nanoparticle-Based Therapeutics. AAPS J. 14 (2), 282\u2013295. 10.1208/s12248-012-9339-4", "ArticleIdList": ["10.1208/s12248-012-9339-4", "PMC3326161", "22407288"]}, {"Citation": "Dizon D. S., Blessing J. A., McMeekin D. S., Sharma S. K., DiSilvestro P., Alvarez R. D. (2009). Phase II Trial of Ixabepilone as Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P. J. Clin. Oncol. 27 (19), 3104\u20133108. 10.1200/jco.2008.20.6995", "ArticleIdList": ["10.1200/jco.2008.20.6995", "PMC2716935", "19451430"]}, {"Citation": "Dobrovolskaia M. A., McNeil S. E. (2007). Immunological Properties of Engineered Nanomaterials. Nat. Nanotechnol 2 (8), 469\u2013478. 10.1038/nnano.2007.223", "ArticleIdList": ["10.1038/nnano.2007.223", "18654343"]}, {"Citation": "Dong J. R., Chang W. W., Chen S. M. (2021). Nerolidol Inhibits Proliferation of Leiomyoma Cells via Reactive Oxygen Species-Induced DNA Damage and Downregulation of the ATM/Akt Pathway. Phytochemistry 191, 112901. 10.1016/j.phytochem.2021.112901", "ArticleIdList": ["10.1016/j.phytochem.2021.112901", "34388663"]}, {"Citation": "Dutta S., Mahalanobish S., Saha S., Ghosh S., Sil P. C. (2019). Natural Products: An Upcoming Therapeutic Approach to Cancer. Food Chem. Toxicol. 128, 240\u2013255. 10.1016/j.fct.2019.04.012", "ArticleIdList": ["10.1016/j.fct.2019.04.012", "30991130"]}, {"Citation": "El Khoury D., Matar R., Touma T. (2019). Curcumin and Endometrial Carcinoma: an Old Spice as a Novel Agent. Int. J. Womens Health 11, 249\u2013256. 10.2147/ijwh.S194262<", "ArticleIdList": ["10.2147/ijwh.S194262", "PMC6586219", "31354362"]}, {"Citation": "Elia U., Flescher E. (2008). PI3K/Akt Pathway Activation Attenuates the Cytotoxic Effect of Methyl Jasmonate toward Sarcoma Cells. Neoplasia 10 (11), 1303\u20131313. 10.1593/neo.08636", "ArticleIdList": ["10.1593/neo.08636", "PMC2570607", "18953440"]}, {"Citation": "Enomoto T., Inoue M., Perantoni A. O., Buzard G. S., Miki H., Tanizawa O., et al. (1991). K-ras Activation in Premalignant and Malignant Epithelial Lesions of the Human Uterus. Cancer Res. 51 (19), 5308\u20135314.", "ArticleIdList": ["1913654"]}, {"Citation": "Fathalla M. F. (1971). Incessant Ovulation-Aa Factor in Ovarian Neoplasia? Lancet 2 (7716), 163. 10.1016/s0140-6736(71)92335-x", "ArticleIdList": ["10.1016/s0140-6736(71)92335-x", "4104488"]}, {"Citation": "Finn R. S., Aleshin A., Slamon D. J. (2016). Targeting the Cyclin-dependent Kinases (CDK) 4/6 in Estrogen Receptor-Positive Breast Cancers. Breast Cancer Res. 18 (1), 17. 10.1186/s13058-015-0661-5", "ArticleIdList": ["10.1186/s13058-015-0661-5", "PMC4746893", "26857361"]}, {"Citation": "Furness S., Roberts H., Marjoribanks J., Lethaby A. (2012). Hormone Therapy in Postmenopausal Women and Risk of Endometrial Hyperplasia. Cochrane Database Syst. Rev. 10.1002/14651858.CD000402.pub4", "ArticleIdList": ["10.1002/14651858.CD000402.pub4", "PMC7039145", "22895916"]}, {"Citation": "Gessner A., Waicz R., Lieske A., Paulke B., M\u00e4der K., M\u00fcller R. H. (2000). Nanoparticles with Decreasing Surface Hydrophobicities: Influence on Plasma Protein Adsorption. Int. J. Pharm. 196 (2), 245\u2013249. 10.1016/s0378-5173(99)00432-9", "ArticleIdList": ["10.1016/s0378-5173(99)00432-9", "10699728"]}, {"Citation": "Gocek E., Moulas A. N., Studzinski G. P. (2014). Non-receptor Protein Tyrosine Kinases Signaling Pathways in normal and Cancer Cells. Crit. Rev. Clin. Lab. Sci. 51 (3), 125\u2013137. 10.3109/10408363.2013.874403", "ArticleIdList": ["10.3109/10408363.2013.874403", "24446827"]}, {"Citation": "Gohulkumar M., Gurushankar K., Rajendra Prasad N., Krishnakumar N. (2014). Enhanced Cytotoxicity and Apoptosis-Induced Anticancer Effect of Silibinin-Loaded Nanoparticles in Oral Carcinoma (KB) Cells. Mater. Sci. Eng. C Mater. Biol. Appl. 41, 274\u2013282. 10.1016/j.msec.2014.04.056", "ArticleIdList": ["10.1016/j.msec.2014.04.056", "24907761"]}, {"Citation": "Gonz\u00e1lez-Aguilar G., Tiznado-Hernandez M., Wang C. (2006). Physiological and Biochemical Responses of Horticultural Products to Methyl Jasmonate. Stewart postharvest Rev. 2 (1), 1\u20139. 10.2212/spr.2006.1.1", "ArticleIdList": ["10.2212/spr.2006.1.1"]}, {"Citation": "Gouveia D. N., Guimar\u00e3es A. G., Santos W. B. D. R., Quintans-J\u00fanior L. J. (2019). Natural Products as a Perspective for Cancer Pain Management: a Systematic Review. Phytomedicine 58, 152766. 10.1016/j.phymed.2018.11.026", "ArticleIdList": ["10.1016/j.phymed.2018.11.026", "31005719"]}, {"Citation": "Gupta T., Singh J., Kaur S., Sandhu S., Singh G., Kaur I. P. (2020). Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for its Effectiveness. Front. Bioeng. Biotechnol. 8, 879. 10.3389/fbioe.2020.00879", "ArticleIdList": ["10.3389/fbioe.2020.00879", "PMC7593682", "33178666"]}, {"Citation": "Han M., Yu X., Guo Y., Wang Y., Kuang H., Wang X. (2014). Honokiol Nanosuspensions: Preparation, Increased Oral Bioavailability and Dramatically Enhanced Biodistribution in the Cardio-Cerebro-Vascular System. Colloids Surf. B Biointerfaces 116, 114\u2013120. 10.1016/j.colsurfb.2013.12.056", "ArticleIdList": ["10.1016/j.colsurfb.2013.12.056", "24448177"]}, {"Citation": "Han Q., Wang X., Cai S., Liu X., Zhang Y., Yang L., et al. (2018). Quercetin Nanoparticles with Enhanced Bioavailability as Multifunctional Agents toward Amyloid Induced Neurotoxicity. J. Mater. Chem. B 6 (9), 1387\u20131393. 10.1039/c7tb03053c", "ArticleIdList": ["10.1039/c7tb03053c", "32254423"]}, {"Citation": "Horst D., Chen J., Morikawa T., Ogino S., Kirchner T., Shivdasani R. A. (2012). Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling. Cancer Res. 72 (6), 1547\u20131556. 10.1158/0008-5472.Can-11-3222", "ArticleIdList": ["10.1158/0008-5472.Can-11-3222", "PMC3571091", "22318865"]}, {"Citation": "Hou D. X., Kumamoto T. (2010). Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling. Antioxid. Redox Signal. 13 (5), 691\u2013719. 10.1089/ars.2009.2816", "ArticleIdList": ["10.1089/ars.2009.2816", "20070239"]}, {"Citation": "Hu H., Hang J. J., Han T., Zhuo M., Jiao F., Wang L. W. (2016). The M2 Phenotype of Tumor-Associated Macrophages in the Stroma Confers a Poor Prognosis in Pancreatic Cancer. Tumour Biol. 37 (7), 8657\u20138664. 10.1007/s13277-015-4741-z", "ArticleIdList": ["10.1007/s13277-015-4741-z", "26738860"]}, {"Citation": "Jeetah R., Bhaw-Luximon A., Jhurry D. (2014). Nanopharmaceutics: Phytochemical-Based Controlled or Sustained Drug-Delivery Systems for Cancer Treatment. J. Biomed. Nanotechnol 10 (9), 1810\u20131840. 10.1166/jbn.2014.1884", "ArticleIdList": ["10.1166/jbn.2014.1884", "25992442"]}, {"Citation": "Jenwitheesuk A., Boontem P., Wongchitrat P., Tocharus J., Mukda S., Govitrapong P. (2017). Melatonin Regulates the Aging Mouse Hippocampal Homeostasis via the Sirtuin1-FOXO1 Pathway. EXCLI J. 16, 340\u2013353. 10.17179/excli2016-852", "ArticleIdList": ["10.17179/excli2016-852", "PMC5427465", "28507478"]}, {"Citation": "Jiang R., Su G., Chen X., Chen S., Li Q., Xie B., et al. (2021). Esculetin Inhibits Endometrial Cancer Proliferation and Promotes Apoptosis via hnRNPA1 to Downregulate BCLXL and XIAP. Cancer Lett. 521, 308\u2013321. 10.1016/j.canlet.2021.08.039", "ArticleIdList": ["10.1016/j.canlet.2021.08.039", "34480971"]}, {"Citation": "Jorda R., Hendrychov\u00e1 D., Voller J., \u0158ezn\u00ed\u010dkov\u00e1 E., Guck\u00fd T., Kry\u0161tof V. (2018). How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-dependent Kinases? J. Med. Chem. 61 (20), 9105\u20139120. 10.1021/acs.jmedchem.8b00049", "ArticleIdList": ["10.1021/acs.jmedchem.8b00049", "30234987"]}, {"Citation": "Kaneuchi M., Sasaki M., Tanaka Y., Sakuragi N., Fujimoto S., Dahiya R. (2003). Quercetin Regulates Growth of Ishikawa Cells through the Suppression of EGF and Cyclin D1. Int. J. Oncol. 22 (1), 159\u2013164. 10.3892/ijo.22.1.159", "ArticleIdList": ["10.3892/ijo.22.1.159", "12469199"]}, {"Citation": "Katoh M., Katoh M. (2007). WNT Signaling Pathway and Stem Cell Signaling Network. Clin. Cancer Res. 13 (14), 4042\u20134045. 10.1158/1078-0432.CCR-06-2316", "ArticleIdList": ["10.1158/1078-0432.CCR-06-2316", "17634527"]}, {"Citation": "Khan N., Bharali D. J., Adhami V. M., Siddiqui I. A., Cui H., Shabana S. M., et al. (2013). Oral Administration of Naturally Occurring Chitosan-Based Nanoformulated green tea Polyphenol EGCG Effectively Inhibits Prostate Cancer Cell Growth in a Xenograft Model. Carcinogenesis 35 (2), 415\u2013423. 10.1093/carcin/bgt321", "ArticleIdList": ["10.1093/carcin/bgt321", "PMC3908746", "24072771"]}, {"Citation": "Kobayashi H., Uekuri C., Akasaka J., Ito F., Shigemitsu A., Koike N., et al. (2013). The Biology of Uterine Sarcomas: A Review and Update. Mol. Clin. Oncol. 1 (4), 599\u2013609. 10.3892/mco.2013.124", "ArticleIdList": ["10.3892/mco.2013.124", "PMC3916197", "24649216"]}, {"Citation": "Kuhn E., Wu R. C., Guan B., Wu G., Zhang J., Wang Y., et al. (2012). Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses. J. Natl. Cancer Inst. 104 (19), 1503\u20131513. 10.1093/jnci/djs345", "ArticleIdList": ["10.1093/jnci/djs345", "PMC3692380", "22923510"]}, {"Citation": "Kuo H.-P., Lee Y.-J., Hsu C.-Y., Lee S.-L., Hsu S.-C., Chuang T.-C., et al. (2015). Growth-suppressive Effect of Berberine on Endometrial Carcinoma Cells: Role of Mitochondrial and PI3K/Akt Pathway. J. Funct. Foods 17, 600\u2013609. 10.1016/j.jff.2015.06.006", "ArticleIdList": ["10.1016/j.jff.2015.06.006"]}, {"Citation": "Lagan\u00e0 P., Anastasi G., Marano F., Piccione S., Singla R. K., Dubey A. K., et al. (2019). Phenolic Substances in Foods: Health Effects as Anti-inflammatory and Antimicrobial Agents. J. AOAC Int. 102 (5), 1378\u20131387. 10.5740/jaoacint.19-0131", "ArticleIdList": ["10.5740/jaoacint.19-0131", "31200787"]}, {"Citation": "Lax S. F., Kendall B., Tashiro H., Slebos R. J., Hedrick L. (2000). The Frequency of P53, K-Ras Mutations, and Microsatellite Instability Differs in Uterine Endometrioid and Serous Carcinoma: Evidence of Distinct Molecular Genetic Pathways. Cancer 88 (4), 814\u2013824. 10.1002/(sici)1097-0142(20000215)88:4<814::Aid-cncr12>3.0.Co;2-u", "ArticleIdList": ["10.1002/(sici)1097-0142(20000215)88:4<814::Aid-cncr12>3.0.Co;2-u", "10679651"]}, {"Citation": "Lax S. F. (2004). Molecular Genetic Pathways in Various Types of Endometrial Carcinoma: from a Phenotypical to a Molecular-Based Classification. Virchows Arch. 444 (3), 213\u2013223. 10.1007/s00428-003-0947-3", "ArticleIdList": ["10.1007/s00428-003-0947-3", "14747944"]}, {"Citation": "Lee Y., Miron A., Drapkin R., Nucci M. R., Medeiros F., Saleemuddin A., et al. (2007). A Candidate Precursor to Serous Carcinoma that Originates in the Distal Fallopian Tube. J. Pathol. 211 (1), 26\u201335. 10.1002/path.2091", "ArticleIdList": ["10.1002/path.2091", "17117391"]}, {"Citation": "Leonarduzzi G., Testa G., Sottero B., Gamba P., Poli G. (2010). Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids. Curr. Med. Chem. 17 (1), 74\u201395. 10.2174/092986710789957760", "ArticleIdList": ["10.2174/092986710789957760", "19941477"]}, {"Citation": "Leslie K. K., Stein M. P., Kumar N. S., Dai D., Stephens J., Wandinger-Ness A., et al. (2005). Progesterone Receptor Isoform Identification and Subcellular Localization in Endometrial Cancer. Gynecol. Oncol. 96 (1), 32\u201341. 10.1016/j.ygyno.2004.09.057", "ArticleIdList": ["10.1016/j.ygyno.2004.09.057", "PMC2755492", "15589577"]}, {"Citation": "Li D., Zhang J., Zhao X. (2021). Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment. Cancer Invest. 39 (8), 675\u2013684. 10.1080/07357907.2021.1954190", "ArticleIdList": ["10.1080/07357907.2021.1954190", "34241563"]}, {"Citation": "Li H., Li M., Fu J., Ao H., Wang W., Wang X. (2021). Enhancement of Oral Bioavailability of Quercetin by Metabolic Inhibitory Nanosuspensions Compared to Conventional Nanosuspensions. Drug Deliv. 28 (1), 1226\u20131236. 10.1080/10717544.2021.1927244", "ArticleIdList": ["10.1080/10717544.2021.1927244", "PMC8218931", "34142631"]}, {"Citation": "Li L. P., Wang X. J., Zhang J. Y., Zhang L. L., Cao Y. B., Gu L. Q., et al. (2018). Antifungal Activity of Osthol in vitro and Enhancement in vivo through Eudragit S100 Nanocarriers. Virulence 9 (1), 555\u2013562. 10.1080/21505594.2017.1356503", "ArticleIdList": ["10.1080/21505594.2017.1356503", "PMC5955437", "28795862"]}, {"Citation": "Li X. L., Ma R. H., Ni Z. J., Thakur K., Cespedes-Acu\u00f1a C. L., Wang S., et al. (2021). Dioscin Inhibits Human Endometrial Carcinoma Proliferation via G0/G1 Cell Cycle Arrest and Mitochondrial-dependent Signaling Pathway. Food Chem. Toxicol. 148, 111941. 10.1016/j.fct.2020.111941", "ArticleIdList": ["10.1016/j.fct.2020.111941", "33359023"]}, {"Citation": "Liang L., Yang B., Wu Y., Sun L. (2021). Osthole Suppresses the Proliferation and Induces Apoptosis via Inhibiting the PI3K/AKT Signaling Pathway of Endometrial Cancer JEC Cells. Exp. Ther. Med. 22 (4), 1171. 10.3892/etm.2021.10605", "ArticleIdList": ["10.3892/etm.2021.10605", "PMC8393372", "34504616"]}, {"Citation": "Lustig B., Behrens J. (2003). The Wnt Signaling Pathway and its Role in Tumor Development. J. Cancer Res. Clin. Oncol. 129 (4), 199\u2013221. 10.1007/s00432-003-0431-0", "ArticleIdList": ["10.1007/s00432-003-0431-0", "12707770"]}, {"Citation": "Madaan R., Singla R. K., Kumar S., Dubey A. K., Kumar D., Sharma P., et al. (2021). Bergenin - a Biologically Active Scaffold: Nanotechnological Perspectives. Ctmc 21. 10.2174/1568026621666211015092654", "ArticleIdList": ["10.2174/1568026621666211015092654", "34649489"]}, {"Citation": "Managuli R. S., Raut S. Y., Reddy M. S., Mutalik S. (2018). Targeting the Intestinal Lymphatic System: a Versatile Path for Enhanced Oral Bioavailability of Drugs. Expert Opin. Drug Deliv. 15 (8), 787\u2013804. 10.1080/17425247.2018.1503249", "ArticleIdList": ["10.1080/17425247.2018.1503249", "30025212"]}, {"Citation": "Mansoori B., Mohammadi A., Amin Doustvandi M., Mohammadnejad F., Kamari F., Gjerstorff M. F., et al. (2019). Photodynamic Therapy for Cancer: Role of Natural Products. Photodiagnosis Photodyn Ther. 26, 395\u2013404. 10.1016/j.pdpdt.2019.04.033", "ArticleIdList": ["10.1016/j.pdpdt.2019.04.033", "PMC6579671", "31063860"]}, {"Citation": "Mao W., Yin H., Chen W., Zhao T., Wu S., Jin H., et al. (2020). Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma. Drug Des. Devel Ther. 14, 2135\u20132147. 10.2147/DDDT.S249651", "ArticleIdList": ["10.2147/DDDT.S249651", "PMC7266311", "32546976"]}, {"Citation": "Markowska A., Pawa\u0142owska M., Lubin J., Markowska J. (2014). Signalling Pathways in Endometrial Cancer. Contemp. Oncol. (Pozn) 18 (3), 143\u2013148. 10.5114/wo.2014.43154", "ArticleIdList": ["10.5114/wo.2014.43154", "PMC4268999", "25520571"]}, {"Citation": "Marzocco S., Singla R. K., Capasso A. (2021). Multifaceted Effects of Lycopene: A Boulevard to the Multitarget-Based Treatment for Cancer. Molecules 26 (17). 10.3390/molecules26175333", "ArticleIdList": ["10.3390/molecules26175333", "PMC8434243", "34500768"]}, {"Citation": "Matias-Guiu X., Prat J. (2013). Molecular Pathology of Endometrial Carcinoma. Histopathology 62 (1), 111\u2013123. 10.1111/his.12053", "ArticleIdList": ["10.1111/his.12053", "23240673"]}, {"Citation": "McMeekin D. S., Manikas G., Crispens M., Orza A. M., Braly P., Doering D., et al. (2004). A Phase II Study of Trabectedin (ET-743) as a Second Line Therapy in Patients with Persistent or Recurrent Endometrial Carcinoma. Jco 22 (14_Suppl. l), 5086. 10.1200/jco.2004.22.90140.5086", "ArticleIdList": ["10.1200/jco.2004.22.90140.5086"]}, {"Citation": "Moghimi S. M., Hunter A. C., Murray J. C. (2001). Long-circulating and Target-specific Nanoparticles: Theory to Practice. Pharmacol. Rev. 53 (2), 283\u2013318.", "ArticleIdList": ["11356986"]}, {"Citation": "Moolgavkar S. H., Knudson A. G. (1981). Mutation and Cancer: a Model for Human Carcinogenesis. J. Natl. Cancer Inst. 66 (6), 1037\u20131052. 10.1093/jnci/66.6.1037", "ArticleIdList": ["10.1093/jnci/66.6.1037", "6941039"]}, {"Citation": "Mortazavi H., Nikfar B., Esmaeili S. A., Rafieenia F., Saburi E., Chaichian S., et al. (2020). Potential Cytotoxic and Anti-metastatic Effects of Berberine on Gynaecological Cancers with Drug-Associated Resistance. Eur. J. Med. Chem. 187, 111951. 10.1016/j.ejmech.2019.111951", "ArticleIdList": ["10.1016/j.ejmech.2019.111951", "31821990"]}, {"Citation": "Muqbil I., Masood A., Sarkar F. H., Mohammad R. M., Azmi A. S. (2011). Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents. Cancers (Basel) 3 (1), 428\u2013445. 10.3390/cancers3010428", "ArticleIdList": ["10.3390/cancers3010428", "PMC3756370", "24212623"]}, {"Citation": "Mutter G. L., Lin M. C., Fitzgerald J. T., Kum J. B., Baak J. P., Lees J. A., et al. (2000). Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers. J. Natl. Cancer Inst. 92 (11), 924\u2013930. 10.1093/jnci/92.11.924", "ArticleIdList": ["10.1093/jnci/92.11.924", "10841828"]}, {"Citation": "Nageen B., Sarfraz I., Rasul A., Hussain G., Rukhsar F., Irshad S., et al. (2020). Eupatilin: a Natural Pharmacologically Active Flavone Compound with its Wide Range Applications. J. Asian Nat. Prod. Res. 22 (1), 1\u201316. 10.1080/10286020.2018.1492565", "ArticleIdList": ["10.1080/10286020.2018.1492565", "29973097"]}, {"Citation": "Oda K., Stokoe D., Taketani Y., McCormick F. (2005). High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma. Cancer Res. 65 (23), 10669\u201310673. 10.1158/0008-5472.Can-05-2620", "ArticleIdList": ["10.1158/0008-5472.Can-05-2620", "16322209"]}, {"Citation": "Okuda T., Sekizawa A., Purwosunu Y., Nagatsuka M., Morioka M., Hayashi M., et al. (2010). Genetics of Endometrial Cancers. Obstet. Gynecol. Int. 2010, 984013\u2013984018. 10.1155/2010/984013", "ArticleIdList": ["10.1155/2010/984013", "PMC2852605", "20396392"]}, {"Citation": "Onstad M. A., Schmandt R. E., Lu K. H. (2016). Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J. Clin. Oncol. 34 (35), 4225\u20134230. 10.1200/JCO.2016.69.4638", "ArticleIdList": ["10.1200/JCO.2016.69.4638", "PMC5455320", "27903150"]}, {"Citation": "Pe\u00f1alva R., Morales J., Gonz\u00e1lez-Navarro C., Larra\u00f1eta E., Quincoces G., Pe\u00f1uelas I., et al. (2018). Increased Oral Bioavailability of Resveratrol by its Encapsulation in Casein Nanoparticles. Ijms 19 (9), 2816. 10.3390/ijms19092816", "ArticleIdList": ["10.3390/ijms19092816", "PMC6163610", "30231546"]}, {"Citation": "Pierpaoli E., Damiani E., Orlando F., Lucarini G., Bartozzi B., Lombardi P., et al. (2015). Antiangiogenic and Antitumor Activities of Berberine Derivative NAX014 Compound in a Transgenic Murine Model of HER2/neu-Positive Mammary Carcinoma. Carcinogenesis 36 (10), 1169\u20131179. 10.1093/carcin/bgv103", "ArticleIdList": ["10.1093/carcin/bgv103", "26168818"]}, {"Citation": "Pourhanifeh M. H., Darvish M., Tabatabaeian J., Fard M. R., Mottaghi R., Azadchehr M. J., et al. (2020). Therapeutic Role of Curcumin and its Novel Formulations in Gynecological Cancers. J. Ovarian Res. 13 (1), 130. 10.1186/s13048-020-00731-7", "ArticleIdList": ["10.1186/s13048-020-00731-7", "PMC7643381", "33148295"]}, {"Citation": "Puszkiel A., No\u00e9 G., Thomas-Schoemann A., Bellesoeur A., Boudou-Rouquette P., Vidal M., et al. (2017). Pharmacokinetics and Pharmacodynamics of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma. Int. J. Pharmacokinet. 2 (4), 257\u2013283. 10.4155/ipk-2017-0008", "ArticleIdList": ["10.4155/ipk-2017-0008"]}, {"Citation": "Rahimi H. R., Nedaeinia R., Sepehri Shamloo A., Nikdoust S., Kazemi Oskuee R. (2016). Novel Delivery System for Natural Products: Nano-Curcumin Formulations. Avicenna J. Phytomed 6 (4), 383\u2013398.", "ArticleIdList": ["PMC4967834", "27516979"]}, {"Citation": "Rahman M., Beg S., Ahmed A., Swain S. (2014). Emergence of Functionalized Nanomedicines in Cancer Chemotherapy: Recent Advancements, Current Challenges and Toxicity Considerations. Pnm 3 (2), 128\u2013139. 10.2174/18779123113036660002", "ArticleIdList": ["10.2174/18779123113036660002"]}, {"Citation": "Richter C., Mayhew D., Rennhack J. P., So J., Stover E. H., Hwang J. H., et al. (2020). Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer. Int. J. Mol. Sci. 21 (22). 10.3390/ijms21228690", "ArticleIdList": ["10.3390/ijms21228690", "PMC7698702", "33217970"]}, {"Citation": "Rosenwald I. B., Rhoads D. B., Callanan L. D., Isselbacher K. J., Schmidt E. V. (1993). Increased Expression of Eukaryotic Translation Initiation Factors eIF-4E and eIF-2 Alpha in Response to Growth Induction by C-Myc. Proc. Natl. Acad. Sci. U S A. 90 (13), 6175\u20136178. 10.1073/pnas.90.13.6175", "ArticleIdList": ["10.1073/pnas.90.13.6175", "PMC46890", "8327497"]}, {"Citation": "S\u00e1nchez-Mart\u00ednez C., Gelbert L. M., Lallena M. J., de Dios A. (2015). Cyclin Dependent Kinase (CDK) Inhibitors as Anticancer Drugs. Bioorg. Med. Chem. Lett. 25 (17), 3420\u20133435. 10.1016/j.bmcl.2015.05.100", "ArticleIdList": ["10.1016/j.bmcl.2015.05.100", "26115571"]}, {"Citation": "Schwartz P. A., Murray B. W. (2011). Protein Kinase Biochemistry and Drug Discovery. Bioorg. Chem. 39 (5-6), 192\u2013210. 10.1016/j.bioorg.2011.07.004", "ArticleIdList": ["10.1016/j.bioorg.2011.07.004", "21872901"]}, {"Citation": "Sexton E., Van Themsche C., Leblanc K., Parent S., Lemoine P., Asselin E. (2006). Resveratrol Interferes with AKT Activity and Triggers Apoptosis in Human Uterine Cancer Cells. Mol. Cancer 5 (1), 45. 10.1186/1476-4598-5-45", "ArticleIdList": ["10.1186/1476-4598-5-45", "PMC1626081", "17044934"]}, {"Citation": "Sherman M. E., Sturgeon S., Brinton L., Kurman R. J. (1995). Endometrial Cancer Chemoprevention: Implications of Diverse Pathways of Carcinogenesis. J. Cell Biochem Suppl 23, 160\u2013164. 10.1002/jcb.240590921", "ArticleIdList": ["10.1002/jcb.240590921", "8747391"]}, {"Citation": "Singh M., Darcy K. M., Brady W. E., Clubwala R., Weber Z., Rittenbach J. V., et al. (2011). Cadherins, Catenins and Cell Cycle Regulators: Impact on Survival in a Gynecologic Oncology Group Phase II Endometrial Cancer Trial. Gynecol. Oncol. 123 (2), 320\u2013328. 10.1016/j.ygyno.2011.07.005", "ArticleIdList": ["10.1016/j.ygyno.2011.07.005", "PMC3518446", "21813170"]}, {"Citation": "Singla R. K., Agarwal T., He X., Shen B. (2021a). Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson's Disease. Curr. Drug Targets 22 (6), 609\u2013630. 10.2174/1389450121999201013155202", "ArticleIdList": ["10.2174/1389450121999201013155202", "33050857"]}, {"Citation": "Singla R. K., Dubey A. K. (2019). Molecules and Metabolites from Natural Products as Inhibitors of Biofilm in Candida Spp. Pathogens. Curr. Top. Med. Chem. 19 (28), 2567\u20132578. 10.2174/1568026619666191025154834", "ArticleIdList": ["10.2174/1568026619666191025154834", "PMC7403689", "31654510"]}, {"Citation": "Singla R. K., Guimar\u00e3es A. G., Zengin G. (2020a). Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation. Front. Pharmacol. 11, 623399. 10.3389/fphar.2020.623399", "ArticleIdList": ["10.3389/fphar.2020.623399", "PMC7841409", "33519489"]}, {"Citation": "Singla R. K., Kumar R., Khan S., MohitKumari K., Kumari K., Garg A. (2019). Natural Products: Potential Source of DPP-IV Inhibitors. Curr. Protein Pept. Sci. 20 (12), 1218\u20131225. 10.2174/1389203720666190502154129", "ArticleIdList": ["10.2174/1389203720666190502154129", "31057098"]}, {"Citation": "Singla R. K. (2021). Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and Their Metabolic Profiling - Part 3. Curr. Drug Metab. 22 (6), 412\u2013414. 10.2174/138920022206210708103019", "ArticleIdList": ["10.2174/138920022206210708103019", "34455943"]}, {"Citation": "Singla R. K., Singla R. K. (2020). Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and Their Metabolic Profiling: Part 1. Curr. Drug Metab. 21 (14), 480\u2013481. 10.2174/138920022107200925101631", "ArticleIdList": ["10.2174/138920022107200925101631", "33172364"]}, {"Citation": "Singla R. K., Sultana A., Alam M. S., Shen B. (2020b). Regulation of Pain Genes-Capsaicin vs Resiniferatoxin: Reassessment of Transcriptomic Data. Front. Pharmacol. 11, 551786. 10.3389/fphar.2020.551786", "ArticleIdList": ["10.3389/fphar.2020.551786", "PMC7658921", "33192502"]}, {"Citation": "Singla R. K., De B., Nagal A. (2018). \u201cMultimodal Perspectives of Nanotechnology and Nanoparticles in Drug Delivery\u201d in Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition, Basel, June 4, 2018 (Basel, Switzerland: MDPI Sciforum; )."}, {"Citation": "Singla R. K., Gupta R., Joon S., Gupta A. K., Shen B. (2021b). Isolation, Docking and In Silico ADME-T Studies of Acacianol: Novel Antibacterial Isoflavone Analogue Isolated from Acacia Leucophloea Bark. Cdm 22, 893\u2013904. 10.2174/1389200222666211005091417", "ArticleIdList": ["10.2174/1389200222666211005091417", "34636294"]}, {"Citation": "Singla R. K., Sai C. S., Chopra H., Behzad S., Bansal H., Goyal R., et al. (2021c). Natural Products for the Management of Castration-Resistant Prostate Cancer: Special Focus on Nanoparticles Based Studies. Front. Cell Dev. Biol. 9. 10.3389/fcell.2021.745177", "ArticleIdList": ["10.3389/fcell.2021.745177", "PMC8602797", "34805155"]}, {"Citation": "Singla R. K., Sharma P., Dubey A. K., Gundamaraju R., Kumar D., Kumar S., et al. (2021d). Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies. Front. Pharmacol. 12. 10.3389/fphar.2021.732266", "ArticleIdList": ["10.3389/fphar.2021.732266", "PMC8560712", "34737700"]}, {"Citation": "Sirotkin A. V. (2021). Effects of Resveratrol on Female Reproduction: A Review Phytother Res. 35 (10), 5502\u20135513. 10.1002/ptr.7185", "ArticleIdList": ["10.1002/ptr.7185", "34101259"]}, {"Citation": "Slater S. J., Seiz J. L., Cook A. C., Stagliano B. A., Buzas C. J. (2003). Inhibition of Protein Kinase C by Resveratrol. Biochim. Biophys. Acta 1637 (1), 59\u201369. 10.1016/S0925-4439(02)00214-4", "ArticleIdList": ["10.1016/S0925-4439(02)00214-4", "12527408"]}, {"Citation": "Soslow R. A., Tornos C., Park K. J., Malpica A., Matias-Guiu X., Oliva E., et al. (2019). Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Int. J. Gynecol. Pathol. 38 (Suppl. 1), S64\u2013S74. 10.1097/PGP.0000000000000518", "ArticleIdList": ["10.1097/PGP.0000000000000518", "PMC6295928", "30550484"]}, {"Citation": "Sultana A., Singla R. K., He X., Sun Y., Alam M. S., Shen B. (2021). Topical Capsaicin for the Treatment of Neuropathic Pain. Curr. Drug Metab. 22 (3), 198\u2013207. 10.2174/1389200221999201116143701", "ArticleIdList": ["10.2174/1389200221999201116143701", "33198614"]}, {"Citation": "Sun Y.-w., Liang H., Zong K.-q., Che X., Meng D.-l. (2021). Green and Facile Preparation and Dual-Enhancement Cytotoxicity of Eupatilin Loaded on Hollow Gold Nanoparticles under Near-Infrared Light. New J. Chem. 45 (34), 15676\u201315681. 10.1039/d1nj02276h", "ArticleIdList": ["10.1039/d1nj02276h"]}, {"Citation": "Tan Z. W., Xie S., Hu S. Y., Liao T., Liu P., Peng K. H., et al. (2016). Caudatin Targets TNFAIP1/NF-\u03baB and Cytochrome C/caspase Signaling to Suppress Tumor Progression in Human Uterine Cancer. Int. J. Oncol. 49 (4), 1638\u20131650. 10.3892/ijo.2016.3662", "ArticleIdList": ["10.3892/ijo.2016.3662", "27633631"]}, {"Citation": "Tang S. M., Deng X. T., Zhou J., Li Q. P., Ge X. X., Miao L. (2020). Pharmacological Basis and New Insights of Quercetin Action in Respect to its Anti-cancer Effects. Biomed. Pharmacother. 121, 109604. 10.1016/j.biopha.2019.109604", "ArticleIdList": ["10.1016/j.biopha.2019.109604", "31733570"]}, {"Citation": "Tashiro H., Blazes M. S., Wu R., Cho K. R., Bose S., Wang S. I., et al. (1997). Mutations in PTEN Are Frequent in Endometrial Carcinoma but Rare in Other Common Gynecological Malignancies. Cancer Res. 57 (18), 3935\u20133940.", "ArticleIdList": ["9307275"]}, {"Citation": "Tewari D., Patni P., Bishayee A., Sah A. N., Bishayee A. (2019). Natural Products Targeting the PI3K-Akt-mTOR Signaling Pathway in Cancer: A Novel Therapeutic Strategy. Semin. Cancer Biol. 10.1016/j.semcancer.2019.12.008", "ArticleIdList": ["10.1016/j.semcancer.2019.12.008", "31866476"]}, {"Citation": "Tran K. Q., Tin A. S., Firestone G. L. (2014). Artemisinin Triggers a G1 Cell Cycle Arrest of Human Ishikawa Endometrial Cancer Cells and Inhibits Cyclin-dependent Kinase-4 Promoter Activity and Expression by Disrupting Nuclear Factor-\u03baB Transcriptional Signaling. Anticancer Drugs 25 (3), 270\u2013281. 10.1097/CAD.0000000000000054", "ArticleIdList": ["10.1097/CAD.0000000000000054", "PMC4172338", "24296733"]}, {"Citation": "Trynda-Lemiesz L. (2004). Paclitaxel-HSA Interaction. Binding Sites on HSA Molecule. Bioorg. Med. Chem. 12 (12), 3269\u20133275. 10.1016/j.bmc.2004.03.073", "ArticleIdList": ["10.1016/j.bmc.2004.03.073", "15158795"]}, {"Citation": "van Leeuwen R. W., van Gelder T., Mathijssen R. H., Jansman F. G. (2014). Drug-drug Interactions with Tyrosine-Kinase Inhibitors: a Clinical Perspective. Lancet Oncol. 15 (8), e315\u201326. 10.1016/s1470-2045(13)70579-5", "ArticleIdList": ["10.1016/s1470-2045(13)70579-5", "24988935"]}, {"Citation": "Whitney C. W., Brunetto V. L., Zaino R. J., Lentz S. S., Sorosky J., Armstrong D. K., et al. (2004). Phase II Study of Medroxyprogesterone Acetate Plus Tamoxifen in Advanced Endometrial Carcinoma: a Gynecologic Oncology Group Study. Gynecol. Oncol. 92 (1), 4\u20139. 10.1016/j.ygyno.2003.09.018", "ArticleIdList": ["10.1016/j.ygyno.2003.09.018", "14751130"]}, {"Citation": "Wong Y. K., Xu C., Kalesh K. A., He Y., Lin Q., Wong W. S. F., et al. (2017). Artemisinin as an Anticancer Drug: Recent Advances in Target Profiling and Mechanisms of Action. Med. Res. Rev. 37 (6), 1492\u20131517. 10.1002/med.21446", "ArticleIdList": ["10.1002/med.21446", "28643446"]}, {"Citation": "Wu W., Wang L., Wang L., Zu Y., Wang S., Liu P., et al. (2018). Preparation of Honokiol Nanoparticles by Liquid Antisolvent Precipitation Technique, Characterization, Pharmacokinetics, and Evaluation of Inhibitory Effect on HepG2 Cells. Int. J. Nanomedicine 13, 5469\u20135483. 10.2147/ijn.S178416", "ArticleIdList": ["10.2147/ijn.S178416", "PMC6149943", "30271141"]}, {"Citation": "Yamada K., Uchiyama A., Uehara A., Perera B., Ogino S., Yokoyama Y., et al. (2016). MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages. Cancer Res. 76 (14), 4283\u20134292. 10.1158/0008-5472.CAN-15-2812", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2812", "PMC5033700", "27197197"]}, {"Citation": "Yang L., Ren S., Xu F., Ma Z., Liu X., Wang L. (2019). Recent Advances in the Pharmacological Activities of Dioscin. Biomed. Res. Int. 2019, 5763602. 10.1155/2019/5763602", "ArticleIdList": ["10.1155/2019/5763602", "PMC6710808", "31511824"]}, {"Citation": "Yeramian A., Moreno-Bueno G., Dolcet X., Catasus L., Abal M., Colas E., et al. (2013). Endometrial Carcinoma: Molecular Alterations Involved in Tumor Development and Progression. Oncogene 32 (4), 403\u2013413. 10.1038/onc.2012.76", "ArticleIdList": ["10.1038/onc.2012.76", "22430211"]}, {"Citation": "Zagouri F., Bozas G., Kafantari E., Tsiatas M., Nikitas N., Dimopoulos M. A., et al. (2010). Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy? Obstet. Gynecol. Int. 2010, 749579\u2013749611. 10.1155/2010/749579", "ArticleIdList": ["10.1155/2010/749579", "PMC2817540", "20148071"]}, {"Citation": "Zhang F., Zhang Y. Y., Sun Y. S., Ma R. H., Thakur K., Zhang J. G., et al. (2019). Asparanin A from Asparagus Officinalis L. Induces G0/G1 Cell Cycle Arrest and Apoptosis in Human Endometrial Carcinoma Ishikawa Cells via Mitochondrial and PI3K/AKT Signaling Pathways. J. Agric. Food Chem. 68 (1), 213\u2013224. 10.1021/acs.jafc.9b07103", "ArticleIdList": ["10.1021/acs.jafc.9b07103", "31861958"]}, {"Citation": "Zhang F., Zhang Y.-Y., Ma R.-H., Thakur K., Han J., Hu F., et al. (2021). Multi-omics Reveals the Anticancer Mechanism of asparagus Saponin-Asparanin A on Endometrial Cancer Ishikawa Cells. Food Funct. 12 (2), 614\u2013632. 10.1039/d0fo02265a", "ArticleIdList": ["10.1039/d0fo02265a", "33338094"]}, {"Citation": "Zhang M., Lu Q., Hou H., Sun D., Chen M., Ning F., et al. (2021). Garcinol Inhibits the Proliferation of Endometrial Cancer Cells by Inducing Cell Cycle Arrest. Oncol. Rep. 45 (2), 630\u2013640. 10.3892/or.2020.7900", "ArticleIdList": ["10.3892/or.2020.7900", "PMC7757109", "33416149"]}, {"Citation": "Zhang X. X., Kan H., Liu Y., Ding W. (2021). Plumbagin Induces Ishikawa Cell Cycle Arrest, Autophagy, and Apoptosis via the PI3K/Akt Signaling Pathway in Endometrial Cancer. Food Chem. Toxicol. 148, 111957. 10.1016/j.fct.2020.111957", "ArticleIdList": ["10.1016/j.fct.2020.111957", "33383144"]}, {"Citation": "Zhang Z. R., Leung W. N., Cheung H. Y., Chan C. W. (2015). Osthole: A Review on its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine. Evid. Based Complement. Alternat Med. 2015, 919616. 10.1155/2015/919616", "ArticleIdList": ["10.1155/2015/919616", "PMC4515521", "26246843"]}, {"Citation": "Zheng X. N., Qiu S., Tang L. S., Ai J. Z., Liao X. Y., Jin K., et al. (2021). Tumor Microenvironment-Based Drug Discovery: a Novel Insight into Bladder Cancer Immunotherapy. Chin. Med. J. (Engl) 134 (15), 1885\u20131886. 10.1097/CM9.0000000000001535", "ArticleIdList": ["10.1097/CM9.0000000000001535", "PMC8367065", "34074846"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "25"}, {"Year": "2022", "Month": "1", "Day": "17"}, {"Year": "2022", "Month": "3", "Day": "10", "Hour": "5", "Minute": "43"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35264951", "PMC8899191", "10.3389/fphar.2022.801733", "801733"]}}], "PubmedBookArticle": []}